In addition, the patient participated in a commercial targeted‐sequencing service, and the results showed that there was a PTEN gene mutation in her tumor (the genomic sequence between base 599 of the coding region and base 5 of the intron 6 was replaced by GAAAT). The gene discussed is PTEN; the disease is neoplasm.